This signifies compliance to current good manufacturing practices in the area of medicine packaging and makes it the only company in the country to get this registration. "This gives us potential to market our products and service in every pharmaceutical market around the world and will also enable our customers to reach markets which lay untapped due to non-USFDA compliance", Mohan Bhandari, managing director, BIL said. Meanwhile, the company is expanding operations with the setting up of a satellite unit in Singapore for servicing the South East Asian markets. This unit will come up this year and the investments for this are yet to be finalised, Bhandari said.